Engineering of needle-free physical methods to target epidermal cells for DNA vaccination.
暂无分享,去创建一个
[1] M. Tanemura,et al. Spatial data analysis by epidermal Langerhans cells reveals an elegant system. , 2001, Journal of dermatological science.
[2] M. Kendall,et al. Intradermal ballistic delivery of micro-particles into excised human skin for pharmaceutical applications. , 2004, Journal of biomechanics.
[3] Mark A. F. Kendall,et al. The gas-dynamic effects of a hemisphere-cylinder obstacle in a shock-tube driver , 2005 .
[4] P. Steinert,et al. Bricks and mortar of the epidermal barrier , 1999, Experimental & Molecular Medicine.
[5] L. Hennighausen,et al. Gene transfer into mammalian cells by jet injection. , 1995, Hybridoma.
[6] Mark A. F. Kendall,et al. The delivery of particulate vaccines and drugs to human skin with a practical, hand-held shock tube-based system , 2002 .
[7] R. Germain,et al. Predominant Role for Directly Transfected Dendritic Cells in Antigen Presentation to CD8+ T Cells after Gene Gun Immunization , 1998, The Journal of experimental medicine.
[8] J. Streilein,et al. On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. , 1989, Journal of immunology.
[9] R. Mumper,et al. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device. , 2003, Journal of biotechnology.
[10] M. Kendall,et al. Effects of relative humidity and ambient temperature on the ballistic delivery of micro-particles to excised porcine skin. , 2004, The Journal of investigative dermatology.
[11] J. Matriano,et al. Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.
[12] G. Lesinski,et al. A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice. , 2001, Vaccine.
[13] N. Ishii,et al. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses. , 2001, Vaccine.
[14] Diane E. Sutter,et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.
[15] A. Eisen,et al. Structure and organization of mammalian stratum corneum. , 1971, Journal of ultrastructure research.
[16] A. Folgori,et al. Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer , 2000, Journal of Virology.
[17] G. Glenn,et al. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin , 2003, Expert review of vaccines.
[18] E. H. Gans,et al. Viscoelastic properties of intact human skin: instrumentation, hydration effects, and the contribution of the stratum corneum. , 1977, The Journal of investigative dermatology.
[19] J. Lévêque,et al. The Essential Stratum Corneum , 2002 .
[20] D. Tang,et al. DNA-based non-invasive vaccination onto the skin. , 1999, Vaccine.
[21] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[22] L. Goldsmith,et al. Topical application of viral vectors for epidermal gene transfer. , 1997, The Journal of investigative dermatology.
[23] W. Silvers,et al. Distribution of ATPase‐positive Langerhans cells in normal adult human skin , 1985, The British journal of dermatology.
[24] Roger W. Ainsworth,et al. Measurements of the gas and particle flow within a converging-diverging nozzle for high speed powdered vaccine and drug delivery , 2004 .
[25] P. A. Raju,et al. Assessment of epidermal cell viability by near infrared multi-photon microscopy following ballistic delivery of gold micro-particles. , 2006, Vaccine.
[26] A. Sintov,et al. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[27] R. Hoffman,et al. The feasibility of targeted selective gene therapy of the hair follicle , 1995, Nature Medicine.
[28] G. Cotsarelis,et al. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex , 2000, Nature Biotechnology.
[29] L. Timares,et al. Quantitative analysis of the immunopotency of genetically transfected dendritic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] F. Pass,et al. Delivery of insulin by jet injection: recent observations. , 2001, Diabetes technology & therapeutics.
[31] D. Tang,et al. Vaccination onto bare skin , 1997, Nature.
[32] Mark A. F. Kendall,et al. A ballistic study of micro-particle penetration to the oral mucosa , 2003 .
[33] M. Wolf,et al. Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously , 2002, Infection and Immunity.
[34] R. Wildnauer,et al. The mechanical properties of stratum corneum. I. The effect of water and ambient temperature on the tensile properties of newborn rat stratum corneum. , 1975, Biochimica et biophysica acta.
[35] B. Wahrén,et al. Protection against influenza virus challenge by topical application of influenza DNA vaccine. , 2001, Vaccine.
[36] R. Mumper,et al. Dendritic cell delivery of plasmid DNA , 2001, Molecular biotechnology.
[37] Mark G. Allen,et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] C. Elmets,et al. Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous Vaccines , 2001, Journal of Virology.
[39] O. S. Fowler,et al. Structure and functions of the skin. , 1844 .
[40] J. Ulmer,et al. Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo , 2000, The Journal of Immunology.
[41] S. Hoath,et al. Formation and function of the stratum corneum , 2002 .
[42] J. Hopewell,et al. The skin: its structure and response to ionizing radiation. , 1990, International journal of radiation biology.
[43] R. Akhurst,et al. Liposome-medicated gene transfer and expression via the skin. , 1995, Human molecular genetics.
[44] R. Wildnauer,et al. Stratum corneum biomechanical properties. I. Influence of relative humidity on normal and extracted human stratum corneum. , 1971, Journal of Investigative Dermatology.
[45] L. Babiuk,et al. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[46] A. Rawlings,et al. The effect of glycerol and humidity on desmosome degradation in stratum corneum , 2004, Archives of Dermatological Research.
[47] B. Berman,et al. Anatomical mapping of epidermal Langerhans cell densities in adults , 1983, The British journal of dermatology.
[48] J. Lander,et al. Taking the jab out of needles. , 1993, The Canadian nurse.
[49] Elaine Fuchs,et al. Getting under the skin of epidermal morphogenesis , 2002, Nature Reviews Genetics.
[50] J. Barbenel,et al. In vitro study of the failure of skin surface after influence of hydration and preconditioning , 1998, Archives of Dermatological Research.
[51] Nathan J. Quinlan,et al. Investigations of gas and particle dynamics in first generation needle-free drug delivery devices , 2001 .
[52] G. Schuler,et al. A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal laser scanning microscope. , 2001, The Journal of investigative dermatology.
[53] Y. Maa,et al. Needle-free epidermal powder immunization , 2002, Expert review of vaccines.
[54] Anoop S Pulickal† ve Andrew J Pollard. Çocuklarda tifonun önlenmesinde Vipolisakkaridi-protein konjuge aşısı: umutmu aldatmacamı? , 2007 .
[55] Mary S. Wu,et al. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. , 2000, Vaccine.